Literature DB >> 27846893

Erratum to: The expression of CXCL13 and its relation to unfavorable clinical characteristics in young breast cancer.

Lujia Chen1, Zhongxi Huang2, Guangyu Yao1, Xiaoming Lyu3, Jinbang Li2, Xiaolei Hu1, Yahong Cai1, Wenji Li1, Changsheng Ye4, Xin Li5.   

Abstract

Entities:  

Year:  2016        PMID: 27846893      PMCID: PMC5111289          DOI: 10.1186/s12967-016-1069-4

Source DB:  PubMed          Journal:  J Transl Med        ISSN: 1479-5876            Impact factor:   5.531


× No keyword cloud information.

Erratum to: Journal of Translational Medicine (2015) 13:168 DOI 10.1186/s12967-015-0521-1

Unfortunately, the original version of this article [1] contained an error. The sequence of the author names was incorrect. The corrected order of the author list can be found in this erratum.
  1 in total

1.  The expression of CXCL13 and its relation to unfavorable clinical characteristics in young breast cancer.

Authors:  Lujia Chen; Zhongxi Huang; Guangyu Yao; Xiaoming Lyu; Jinbang Li; Xiaolei Hu; Yahong Cai; Wenji Li; Xin Li; Changsheng Ye
Journal:  J Transl Med       Date:  2015-05-20       Impact factor: 5.531

  1 in total
  4 in total

1.  Signaling via the CXCR5/ERK pathway is mediated by CXCL13 in mice with breast cancer.

Authors:  Licheng Xu; Zhi Liang; Shuyan Li; Jianjun Ma
Journal:  Oncol Lett       Date:  2018-04-17       Impact factor: 2.967

2.  Involvement of the fecal amino acid profile in a clinical and anthropometric study of Mexican patients with insulin resistance and type 2 diabetes mellitus.

Authors:  Mayra Paloma Macías-Acosta; Lorena Valerdi-Contreras; Ericka Denise Bustos-Angel; Rudy Antonio García-Reyes; Monserrat Alvarez-Zavala; Marisela González-Ávila
Journal:  Amino Acids       Date:  2021-11-25       Impact factor: 3.520

3.  A long non-coding RNA LINC00461-dependent mechanism underlying breast cancer invasion and migration via the miR-144-3p/KPNA2 axis.

Authors:  Qiang Zhang; Xiaoyan Jin; Wenbiao Shi; Xin Chen; Wenyang Pang; Xiaodong Yu; Linjun Yang
Journal:  Cancer Cell Int       Date:  2020-04-26       Impact factor: 5.722

4.  An Integrated Pan-Cancer Analysis of 33 Human Cancers Reveals the Potential Clinical Implications and Immunotherapeutic Value of C-X-C Motif Chemokine Ligand 13.

Authors:  Huanyu Zhang; Honghao Yin; Jing Chen; Yuan Yuan
Journal:  Front Oncol       Date:  2022-01-24       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.